Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended-release methylphenidate maintenance for methamphetamine dependence
ChiCTR-TRC-13003347Phase 2Completed
- Sponsor
- Ningbo Addiction Research and Treatment Center
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of methylphenidate in methamphetamine use disorder (MUD) (2 arms), sponsored by Ningbo Addiction Research and Treatment Center. Primary endpoints: time of abstinence and reduction of methamphetamine use. Started Jan 2014; status: completed.
02
Drugs
methylphenidate
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on ChiCTR-TRC-13003347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003347.